Skip to main content
Xenetic Biosciences, Inc. (XBIO)
NASDAQ: XBIO · Real-Time Price · USD
3.130
+0.100 (3.30%)
At close: Apr 28, 2026, 4:00 PM EDT
3.000
-0.130 (-4.15%)
Pre-market: Apr 29, 2026, 4:00 AM EDT

Xenetic Biosciences Revenue

In the year 2025, Xenetic Biosciences had annual revenue of $2.98M with 19.04% growth. Xenetic Biosciences had revenue of $766.30K in the quarter ending December 31, 2025, with 18.11% growth.

Revenue (ttm)
$2.98M
Revenue Growth
+19.04%
P/S Ratio
2.41
Revenue / Employee
$1,488,206
Employees
2
Market Cap
7.17M

Revenue Chart

History

Fiscal Year End Revenue Change Growth
Dec 31, 20252.98M476.13K19.04%
Dec 31, 20242.50M-39.70K-1.56%
Dec 31, 20232.54M833.06K48.80%
Dec 31, 20221.71M546.23K47.06%
Dec 31, 20211.16M723.75K165.64%
Dec 31, 2020 Pro Pro Pro
Dec 31, 2019 Pro Pro Pro
Dec 31, 2018 Pro Pro Pro
Dec 31, 2017 Pro Pro Pro
Dec 31, 2016 Pro Pro Pro

Revenue Definition

Revenue, also called sales, is the amount of money a company receives from its business activities, such as sales of products or services. Revenue does not take any expenses into account and is therefore different from profits.

Full Definition

Related Stocks

Company Name Revenue
Immuron 4.99M
BioAtla 2.00M
Can-Fite BioPharma 405.00K
Addex Therapeutics 198.82K
Silo Pharma 72.10K
Alaunos Therapeutics 5.00K
Revenue Rankings

XBIO News

More News